Contrasting BioLife Solutions (NASDAQ:BLFS) and Akanda (NASDAQ:AKAN)

Akanda (NASDAQ:AKAN) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Risk & Volatility

Akanda has a beta of 14.49, meaning that its stock price is 1,349% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500.

Profitability

This table compares Akanda and BioLife Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Akanda	N/A	N/A	N/A
BioLife Solutions	-2.80%	1.81%	1.65%

Institutional and Insider Ownership

1.0% of Akanda shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 20.4% of Akanda shares are owned by company insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Akanda and BioLife Solutions”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akanda	$840,000.00	15.34	-$4.10 million	N/A	N/A
BioLife Solutions	$96.21 million	10.75	-$4.59 million	($0.08)	-264.63

Akanda has higher earnings, but lower revenue than BioLife Solutions.

Analyst Ratings

This is a summary of current ratings for Akanda and BioLife Solutions, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akanda	1	0	0	0	1.00
BioLife Solutions	1	0	3	1	2.80

BioLife Solutions has a consensus target price of $32.00, suggesting a potential upside of 51.16%. Given BioLife Solutions’ stronger consensus rating and higher possible upside, analysts plainly believe BioLife Solutions is more favorable than Akanda.

Summary

BioLife Solutions beats Akanda on 8 of the 13 factors compared between the two stocks.

About Akanda

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

About BioLife Solutions

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.